Both in Pharmaceuticals
Sagimet Biosciences Inc. Series A vs Altimmune
Over the past year SGMT returned +34.8% and ALT returned −21.6%; their daily moves had a correlation of 0.24.
SGMT +34.8% ALT −21.6%Growth of $1, one year, split-adjusted
| Metric | SGMT | ALT |
|---|---|---|
| Price | $9.33 | $2.97 |
| Market cap | $579.9M | $577.7M |
| Today | −6.14% | +0.34% |
| 1 month | −11.6% | −4.5% |
| 6 months | +105.1% | +3.1% |
| Year to date | +57.6% | −17.7% |
| 1 year | +27.1% | −25.8% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 18,636.1× |
| Net cash | $240.1M | $291.5M |
| Dividend yield | — | — |
| Volatility (60d) | 69.4% | 46.0% |
| Short % of float | 36.3% | 28.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).